Integra LifeSciences Initiates Pediatric AERA Registry
Integra LifeSciences Holding Corporation (Nasdaq: IART), a premier global leader in medical technology, has taken a significant step forward by enrolling the first patient in the Acclarent AERA Pediatric Registry. This multi-center observational registry aims to evaluate the real-world applications of the AERA Eustachian Tube Balloon Dilation System in pediatric patients.
The Purpose Behind the AERA Pediatric Registry
The launch of this registry reflects a dedicated effort to assess the clinical performance of AERA in children suffering from obstructive Eustachian tube dysfunction (ETD). Dr. Prasad Thottam, affiliated with Michigan Pediatric ENT Associates, celebrated this inaugural enrollment, emphasizing the pride in being the first to register a patient for this important initiative.
Comprehensive Data Collection and Analysis
The Acclarent AERA Pediatric Registry is strategically designed to monitor both safety and efficacy outcomes from around 300 pediatric patients who will undergo Eustachian tube balloon dilation (ETBD) using the AERA system. Dr. Thottam noted, “Our ongoing commitment to understanding and treating pediatric Eustachian tube dysfunction underscores the importance of this registry.” He added that this advancement signifies a collaborative goal to enhance pediatric ear, nose, and throat (ENT) care and underscores Integra's dedication to supporting safe and evidence-based medical innovations.
Registry Goals and Objectives
One of the registry's primary objectives is to achieve a failure-free status following ETBD with the AERA device. Failure is classified as the necessity for revision surgery, which could include further ETBD sessions, tympanostomy tube placements, or adenoidectomies due to ongoing ETD issues. Additionally, secondary benchmarks encompass various assessments, such as tympanogram results, pure tone audiometry, and patient-reported experiences.
Evaluating Safety and Effectiveness
The registry is set to gather critical insights on successful balloon dilation rates throughout procedures, while closely monitoring any adverse events or complications that arise as part of the safety evaluation framework. Integra anticipates participation from up to 20 locations across the U.S., promising a diverse and rich data repository that will not only enhance understanding but also foster improved reimbursement policies and clinical acceptance.
About Integra LifeSciences
Integra LifeSciences has its mission rooted in the restoration of patient lives through innovative treatment pathways. They focus on enhancing patient outcomes while also setting new benchmarks in surgical, neurologic, and regenerative care. Their extensive portfolio champions high-quality, leading medical technology, all aimed at advancing healthcare.
Further Information on Integra LifeSciences
For those interested in keeping up with the latest developments regarding Integra and their comprehensive array of products, details can be found on their official website. This serves as a valuable resource for healthcare professionals and patients alike, aiming for better health outcomes through cutting-edge medical solutions.
Frequently Asked Questions
What is the Acclarent AERA Pediatric Registry?
The registry is a multi-center observational study aimed at evaluating the use of the AERA Eustachian Tube Balloon Dilation System in treating pediatric patients with Eustachian tube dysfunction.
Who is involved in the registry?
The registry involves pediatric ENT specialists and will enroll up to 300 young patients across various sites in the U.S.
What type of data will the registry collect?
The registry will collect safety and efficacy outcomes from procedures, including success rates, audiology assessments, and patient-reported feedback.
Why is the registry important?
This registry aims to improve understanding of ETD treatments and optimize pathways for reimbursement and clinical adoption of innovative treatments in pediatric care.
How can I learn more about Integra LifeSciences?
For more information and the latest updates, visit Integra LifeSciences’ official website, which provides insights into their products and advancements in medical technology.
